O
Outcomes4Me
On a mission to improve health outcomes by empowering patients with understandable, relevant, and evidence-based information
About Outcomes4Me
Outcomes4Me is a pioneering healthcare technology company that offers an award-winning app designed to support cancer patients. The app provides free access to evidence-based resources and oncologist-approved guidance, helping patients manage their treatment options, stay updated with the latest research, and track symptoms or medications. Outcomes4Me primarily serves cancer patients, particularly those dealing with breast cancer, by integrating with the NCCN Clinical Practice Guidelines in Oncology, a set of guidelines developed by a not-for-profit alliance of 33 leading cancer centers. The company operates in the digital health market, focusing on patient empowerment and improved quality of life through technology. Outcomes4Me's business model revolves around offering a free app to patients while potentially partnering with healthcare providers, pharmaceutical companies, and research institutions for revenue generation. The company makes money through these partnerships, which may include data sharing agreements, sponsored content, or premium services for healthcare professionals.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Boston, United States
- Employees
- 33
- Open positions
- 8
- Dealroom signal
- 88.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Oncology, Drug Development, Precision Medicine, Biotech and Pharma, Techbio, Hard Tech, DT and LS, science-based
- Technology
- Mobile app
- Client focus
- b2c
- Investment activity
- 2 companies, latest May 2026
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | May 2025 | $21M | $84M | Northpond Ventures · Forecast Labs · Sierra Ventures · LabCorp | ↗ |
| EARLY VC✓Equity / VC | Sep 2023 | $0 | — | Forecast Labs · LabCorp | ↗ |
Growth signals
Latest recorded traffic for Outcomes4Me is 48K monthly website visits, up 37.1% over the last three months. Outcomes4Me's team grew 10% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Geno.MeMadison, United StatesThe world's first searchable ecosystem of linked genetic and medical data
$8.8Mvaluation
RealyzePittsburgh, United StatesCombining the latest in AI technology with clinical expertise to provide better healthcare insights and drive outcomes
→
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A9 investors entered at this stage
Sierra Ventures
Asset Management Ventures
National Cancer Institute SBIR Development Center- MLMerstal Ltd
Northpond Ventures
IRA Capital
Forecast Labs
LabCorp
Salica Investments
Other known investors2 additional known investors
Arjun Kapur
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Outcomes4Me on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Outcomes4Me’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.